NCT06909565ClinicalTrials.gov
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)
בקצרה
V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an adjunct with statin therapy and on…
שלב 4דרושים 6,000 משתתפים153 אתריםמדינה אחת
קטגוריות
רשום במרשם אחד
- ClinicalTrials.govNCT06909565פתיחת רשומה זו ב־ClinicalTrials.govסונכרן שלשום
מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.
מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.
מתעניינים במחקר הזה?
התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2025-04-03; recorded start 2025-07-23
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 475 other studies in this databaseCounted from the lead sponsor named in the record (Duke University)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 2 conditions.
- Lead sponsor type recorded as: other.
- Intervention regulatory context: investigational, within a phased regulatory pathway.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A definitive-grade design for a phase 4 study, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding20/20
Quadruple-blind
- Control arm15/15
Active-comparator control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type10/10
Mortality / MACE endpoint (hard clinical outcome)
- Multi-centre8/8
Multi-centre: 115 sites
- Data monitoring committee7/7
A data monitoring committee is in place
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 6,000 participants (target), run at 153 sites.
How this score is built
- Enrolment36/40
6,000 participants (target)
- Site count23/25
115 sites
- Country count0/15
Single country
- Planned duration9/10
Planned over about 53 months
- Sponsor scale10/10
Duke University has led 456 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
תקציר
V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an adjunct with statin therapy and on the market to lower LDL-C in high-risk populations.
מצבים רפואיים
- Percutaneous Coronary Intervention
- Peripheral Endovascular Intervention
זכאות
| מין | הכול |
|---|---|
| גילאים | 18 Years – ללא מקסימום |
| מתנדבים בריאים | לא |
זכאות כפי שנכתבה במרשם
זכאות במשפטים פשוטים
הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.
תכנון המחקר
| סוג המחקר | התערבותי |
|---|---|
| שלב | שלב 4 |
| הקצאה | אקראי |
| מודל ההתערבות | PARALLEL |
| מטרה ראשית | PREVENTION |
| הסתרה | QUADRUPLE (4) |
| גיוס | דרושים 6,000 משתתפים |
נותן חסות ושותפים
- Duke University נותן חסות
- Novartis Pharmaceuticals שותפים
- Colorado Prevention Center שותפים
- Mount Sinai Hospital, New York שותפים
זרועות והתערבויות
- Inclisiran SodiumACTIVE_COMPARATOR
Inclisiran sodium 300 mg subcutaneous injection
- PlaceboPLACEBO_COMPARATOR
Normal saline 1.5 ml subcutaneous injection
התערבויות
- תרופה Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
300 mg (equivalent to 284 mg inclisiran) in 1.5 mL subcutaneous injection at Day 0; Day 90; \& every 6 months thereafter
- תרופה Normal Saline (Placebo)
Normal saline placebo subcutaneous injection given at Day 0, Day 90; \& every 6 months thereafter
מדדי תוצאה
מדד תוצאה ראשוני
Total number of major adverse cardiovascular events (MACE) after coronary or peripheral endovascular revascularization
MACEs include CHD death, non-fatal MI, ischemic stroke, ALI, major (above the ankle) amputation of vascular etiology, clinically driven coronary and limb revascularization.
מסגרת זמן From randomization to first occurrence of MACE (up to approximately 4 years)
מדד תוצאה ראשוני
Total number of major adverse limb events (MALE) after endovascular revascularization
MALEs consist of ALI, major amputation of vascular etiology, clinically driven lower extremity peripheral revascularization.
מסגרת זמן From randomization to first occurrence of MALE (up to approximately 4 years)
מדד תוצאה משני
Number of participants with cardiovascular (CV) death
מסגרת זמן From randomization to CV death (up to approximately 4 years)
מדד תוצאה משני
Number of participants with all cause death
מסגרת זמן From randomization to all cause death (up to approximately 4 years)
מדד תוצאה משני
Number of participants with venous thromboembolic events (VTE)
מסגרת זמן From randomization to first VTE (up to approximately 4 years)
תאריכים
| תאריך התחלה | 23 ביולי 2025 (בפועל) |
|---|---|
| סיום ראשוני | 1 באוקטובר 2029 (משוער) |
| סיום | 1 בדצמבר 2029 (משוער) |
| פורסם לראשונה | 3 באפריל 2025 (בפועל) |
| עודכן לאחרונה | 16 בנובמבר 2026 |
| התוצאות פורסמו | לא צוין ברשומת המרשם |
| המצב אומת לאחרונה | יולי 2026 |
בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.
מיקומים
149 אתרים מגייסים
United States
| מתקן | עיר | מדינה או אזור | מצב |
|---|---|---|---|
| Capital Cardiology Associates | Albany | New York | מגייס |
| Presbyterian Heart Group | Albuquerque | New Mexico | מגייס |
| Advanced Cardiovascular LLC | Alexander City | Alabama | מגייס |
| Amarillo Heart Clinical Research Institute, Inc. | Amarillo | Texas | מגייס |
| PharmaTex Research | Amarillo | Texas | מגייס |
| AnMed Health Medical Center | Anderson | South Carolina | מגייס |
| Asheville Cardiology Associates Research Department | Asheville | North Carolina | מגייס |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | מגייס |
| Austin Heart | Austin | Texas | מגייס |
| IMS Cardiology | Avondale | Arizona | מגייס |
| Northern Light Eastern Maine Medical Center | Bangor | Maine | מגייס |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | מגייס |
| Pacific Oaks Medical Group | Beverly Hills | California | מגייס |
| Cardiology, PC | Birmingham | Alabama | מגייס |
| Grace Research, LLC | Bossier City | Louisiana | מגייס |
| Bridgeport Hospital | Bridgeport | Connecticut | מגייס |
| Advanced Heart Care LLC | Bridgewater | New Jersey | מגייס |
| Trinity Medical WNY, PC | Buffalo | New York | מגייס |
| Sisters of Charity Hospital | Buffalo | New York | מגייס |
| Capital Area Research LLC | Camp Hill | Pennsylvania | מגייס |
| Aultman Hospital | Canton | Ohio | מגייס |
| Wellspan Chambersburg Hospital | Chambersburg | Pennsylvania | מגייס |
| Mecklenburg Heart Specialists | Charlotte | North Carolina | מגייס |
| Novant Health Clinical Research/Heart & Vascular Institute | Charlotte | North Carolina | מגייס |
| Atrium Health-Sanger Heart and Vascular Institute | Charlotte | North Carolina | מגייס |
| University of Illinois Chicago | Chicago | Illinois | מגייס |
| Cardiovascular Institute of San Diego | Chula Vista | California | מגייס |
| Clearwater Cardiovascular Consultants | Clearwater | Florida | מגייס |
| BayCare Medical Group | Clearwater | Florida | מגייס |
| MedStar Southern Maryland Hospital Center | Clinton | Maryland | מגייס |
| University of Missouri Health Care | Columbia | Missouri | מגייס |
| John Muir Medical Center - Concord Campus | Concord | California | מגייס |
| Javara inc. | Conroe | Texas | בוטל |
| Pioneer Clinical Studies | Coral Gables | Florida | מגייס |
| Valley Clinical Trials | Covina | California | בוטל |
| Louisiana Heart Center | Covington | Louisiana | מגייס |
| Nuvance Health- Danbury Hospital | Danbury | Connecticut | מגייס |
| Cardiology Research Associates | Daytona Beach | Florida | מגייס |
| Arrow Clinical Trails | Daytona Beach | Florida | מגייס |
| Essentia Health-SMMC | Duluth | Minnesota | מגייס |
| Aspirus Saint Luke's Hospital | Duluth | Minnesota | מגייס |
| Midwest Cardiovascular Research and Education Foundation | Elkhart | Indiana | מגייס |
| Cardiovascular Associates of the Delaware Valley | Elmer | New Jersey | מגייס |
| Aurora Denver Cardiology Associates - Englewood | Englewood | Colorado | מגייס |
| Javara Inc. | Fayetteville | North Carolina | מגייס |
| Advanced Heart and Vascular Institute Of Hunterdon | Flemington | New Jersey | מגייס |
| Northeast Georgia Heart Center, PC | Gainesville | Georgia | מגייס |
| Stern Cardiovascular Center | Germantown | Tennessee | מגייס |
| Thrive Clinical Research Group | Glendora | California | מגייס |
| CHI Health Nebraska Heart | Grand Island | Nebraska | מגייס |
103 אתרים נוספים מצוינים ברשומת המרשם.
מסמכי המחקר
לא צורפו מסמכים ברשומת מרשם זו.
שינויים לאורך זמן
- 16 בנובמבר 2026
אתר נוסף
4 sites added (153 total)
149153
- 29 באוקטובר 2026
אתר נוסף
2 sites added (149 total)
147149
- 23 באוקטובר 2026
אתר נוסף
2 sites added (147 total)
145147
- 19 באוקטובר 2026
אתר נוסף
3 sites added (145 total)
142145
- 5 באוקטובר 2026
אתר נוסף
1 site added (142 total)
141142
- 28 בספטמבר 2026
אתר נוסף
2 sites added (141 total)
139141
- 22 בספטמבר 2026
אתר נוסף
1 site added (139 total)
138139
- 15 בספטמבר 2026
אתר נוסף
2 sites added (138 total)
136138
- 28 באוגוסט 2026
אתר נוסף
3 sites added (136 total)
133136
- 18 באוגוסט 2026
אתר נוסף
8 sites added (133 total)
125133
- 5 באוגוסט 2026
אתר נוסף
10 sites added (125 total)
115125